U. Conrad

Prospective monitoring of circulating tumor cells in breast cancer patients treated with primary systemic therapy—A translational project of the German Breast Group study GeparQuattro

S. Loibl, K. Pantel, M. Untch, 2007 .

PREPARE trial. A randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF with a standard dosed epirubicin/cyclophosphamide followed by paclitaxel ± darbepoetin alfa in primary breast cancer: A preplanned interim analysis of eff

P. Fasching, S. Loibl, I. Bauerfeind, 2008 .

PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel ± darbepoetin alfa in primary breast cancer--results at the time of surgery.

N Harbeck, W Fett, S Loibl, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel, and CMF versus a standard-dosed epirubicin-cyclophosphamide followed by paclitaxel with or without darbepoetin alfa in primary breast cancer--outcome on prognosi

N Harbeck, W Fett, S Loibl, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

12 Monitoring serum HER2 levels in the neoadjuvant “Geparquattro” trial – a decrease predicts pathological complete remission

T. Fehm, S. Loibl, M. Untch, 2010 .